XML 34 R20.htm IDEA: XBRL DOCUMENT v3.25.3
SHAREHOLDERS' EQUITY
 9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
SHAREHOLDERS' EQUITY SHAREHOLDERS' EQUITY
During the nine months ended September 30, 2025, we repurchased 6.7 million shares of common stock for $259.9 million under our securities repurchase program (including $1.0 million of repurchases settled in the fourth quarter of 2025). The Company had remaining repurchase authority of $480.4 million as of September 30, 2025.

During the nine months ended September 30, 2025, we issued 0.9 million shares of common stock, net of shares withheld to pay tax withholdings, pursuant to employee benefit plans.

During the nine months ended September 30, 2025, dividends declared on common stock totaled $50.0 million ($0.50 per common share). In May 2025, the Company increased its quarterly common stock dividend to $0.17 per share from $0.16 per share.

Accumulated other comprehensive loss, included in shareholders' equity as of September 30, 2025 and December 31, 2024, is comprised of the following (dollars in millions):
September 30,
2025		December 31,
2024
Net unrealized losses on investments having no allowance for credit losses (a)
$(628.1)$(1,281.6)
Unrealized losses on investments with an allowance for credit losses (1,155.5)(1,108.7)
Change in discount rates for liability for future policy benefits340.7 624.5 
Change in instrument-specific credit risk for market risk benefits0.8 1.4 
Deferred income tax assets323.2 393.0 
Accumulated other comprehensive loss$(1,118.9)$(1,371.4)
___________
(a)     The amortized cost and fair value of fixed maturity securities, available for sale, for which we have elected the fair value option were $39.9 million and $41.1 million, respectively, as of September 30, 2025. Accordingly, the net unrealized losses associated with these investments are excluded from accumulated other comprehensive loss. There were no fixed maturity securities, available for sale, for which we have elected the fair value option as of December 31, 2024.